Works by Xiang, Hao


Results: 555
    1
    2
    3
    4
    5
    6

    Garsorasib, a KRAS G12C inhibitor, with or without cetuximab, an EGFR antibody, in colorectal cancer cohorts of a phase II trial in advanced solid tumors with KRAS G12C mutation.

    Published in:
    Signal Transduction & Targeted Therapy, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41392-025-02274-z
    By:
    • Ruan, Dan-Yun;
    • Wu, Hao-Xiang;
    • Xu, Ye;
    • Munster, Pamela N.;
    • Deng, Yanhong;
    • Richardson, Gary;
    • Yan, Dong;
    • Lee, Myung-Ah;
    • Lee, Keun-Wook;
    • Pan, Hongming;
    • Hager, Steven;
    • Li, Xingya;
    • Wei, Shaozhong;
    • Hou, Xinfang;
    • Underhill, Craig;
    • Millward, Michael;
    • Nordman, Ina;
    • Zhang, Jingdong;
    • Shan, Jianzhen;
    • Han, Guohong
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48

    Multimodal GPT model for assisting thyroid nodule diagnosis and management.

    Published in:
    NPJ Digital Medicine, 2025, v. 8, n. 1, p. 1, doi. 10.1038/s41746-025-01652-9
    By:
    • Yao, Jincao;
    • Wang, Yunpeng;
    • Lei, Zhikai;
    • Wang, Kai;
    • Feng, Na;
    • Dong, Fajin;
    • Zhou, Jianhua;
    • Li, Xiaoxian;
    • Hao, Xiang;
    • Shen, Jiafei;
    • Zhao, Shanshan;
    • Gao, Yuan;
    • Wang, Vicky;
    • Ou, Di;
    • Li, Wei;
    • Lu, Yidan;
    • Chen, Liyu;
    • Yang, Chen;
    • Wang, Liping;
    • Feng, Bojian
    Publication type:
    Article
    49
    50